mr5neak

BOT - Wyckoff Accumulation Schematic

Long
ASX:BOT   BOTANIX PHARMACEUTICALS LTD
Potentially accumulating right now, publishing so that I can follow to see what happens on this one! Note that I've charted using Heikin Ashi as it paints a clearer picture on this. I've drawn roughly what you'd expect to see from here if we are in an accumulation range.

Phase A:
The Preliminary Support (PS) indicates that some buyers are showing up, but still not enough to stop the downward move.Selling Climax (SC) formed by an intense selling activity as investors capitulate. Strong drop quickly reverts into a bounce or Automatic Rally (A R)Secondary Test (ST) happens when the market heads back near the SC region as a test confirming whether the downtrend is really over or not. Trading volume should be noticeably lower. Often the ST will form a higher low than SC but this isn't imperative.

Phase B:
'The Cause that leads to an Effect' - essentially, Phase B is consolidation where Smart Money is accumulating again. There may be multiple ST's during Phase B with the potential for higher highs and lower lows in relation to SC and AR from Phase A.

Phase C:
The Spring - essentially the Bear Trap before moving toward higher lows. The Spring should trigger stop losses from people who have entered during Phase A and B lows. Smart Money back at it again faking out retailers like us making us think we're heading low keeping us on the side before moving up. Note that a Spring won't always occur during Accumulation.

Phase D:
'The transition between the Cause and Effect' - expect an increase in trading volume and volatility. Usually a Last Point Support (LPS) making a higher low before the market moves higher. The LPS often precedes a breakout of resistance levels which creates higher highs. This is an indication of Signs of Strength (SOS) as previous resistance becomes support.

Phase E:
Evident breakout of the trading range, caused by increased market demand. The trading range is effectively broken, and the uptrend begins.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.